Previously, we identified 3 overlapping regions showing loss of heterozygosity (LOH, R 1 -R 3 from 11 to 30 cM) on chromosome 17 in 45 primary gastric cancers (GCs). The data indicated the presence of tumor suppressor genes (TSGs) on chromosome 17 involved in GC. Among the putative TSGs in these regions, HIC1 (in SR 1 ) and TOB1 (in SR 3 ) remain to be examined in GC. By immunohistochemistry (IHC), methylation-specific PCR (MSP) and western blot, we evaluated the expression and regulation status for HIC1 and TOB1 protein in GC. We narrowed down the deletion intervals on chromosome 17 and defined five smaller LOH subregions, SR 1 -SR 5 (0.54 to 3.42 cM), in GC. We found that HIC1 had downregulated expression in 86% (91/106) and was methylated in 87% (26/30) of primary GCs. Of the primary GCs showing downregulation of HIC1 protein, 75% (18/24) had methylated HIC1 gene. TOB1 was either absent or expressed at reduced levels in 75% (73/97) of the GC samples. In addition, a general reduction was found in total and the ratio of unphosphorylated to phosphorylated TOB1 protein levels in the differentiated GC cell lines. Further analysis revealed significant simultaneous downregulation of both HIC1 and TOB1 protein in GC tissue microarray samples (67%, 52/78) and in primary GCs (65%, 11/17). These results indicate that silencing of HIC1 and TOB1 expression is a common occurrence in GC and may contribute to the development and progression of the disease.
INTRODUCTION
Inactivation of tumor-suppressor genes (TSGs) is one of the critical events leading to gastric carcinoma (GC) development and progression. Highly polymorphic microsatellite markers have been used to determine overlapping deleted regions by comparison of tumor DNA with matched control DNA (Russell et al., 2000) . Loss of heterozygosity (LOH) studies have revealed that allelic imbalance of chromosome 17 loci occurs frequently in sporadic GC. The common regions of loss have been mapped to 17p13.1 (Dockhorn et al., 1994 ), 17p13.3 (Wang et al., 1997 ), 17q21 (Semba et al., 1998 ) and 17q24-25 (Petty et al., 1998 .
However, contradictory results have been reported concerning the incidence of LOH on chromosome 17 in GC (Noguchi et al., 2001) . Furthermore, most of the LOH studies performed on chromosome 17 to date have used only a limited number of markers, and a detailed deletion map of overlapping regions on chromosome 17 has not yet been made in sporadic GC. Our previous study demonstrated three overlapping regions of deletion ranging from 11 to 30 cM (R 1 at 17p12-13.3, R 2 at 17q21.3-22 and R 3 at 17q25.3), which highlighted the association of LOH on chromosome 17 with GC pathogenesis (Yu et al., 2008) . To achieve a more precise mapping of the locations of putative TSGs on the chromosome involved in GC, in the present study we narrowed these intervals using high-density genome scanning and defined five smaller overlapping subregions of LOH in GC samples. There are several putative TSGs in SR 1 -SR 3 , however, in our study, we focused on the hypermethylated in cancer 1 (HIC1) gene (in SR 1 ) and TOB1 (in SR 3 ) gene which are two genes that have not been investigated in GC.
The HIC1 gene is an interesting candidate TSG located in the overlapping LOH subregion of LOH in chromosome 17p13.3 (SR 1 ). It encodes a zinc-finger transcription regulator that contains an NH 2 -terminal BTB-POZ domain characteristic of a family of repressors. The gene is ubiquitously expressed in normal tissues, but a decrease or loss of expression was found in several types of tumors (Wales et al., 1995) . HIC1 is considered a likely candidate for a TSG because it has been demonstrated to have a growth suppressive effect when re-expressed in tumor cells in vitro, and has been implicated in the lung, ovary, brain, breast and colon tumorigenesis (Feng et al., 2008; Hayashi et al., 2001) . Indeed, there is accumulating evidence indicating that a change in HIC1 expression through epigenetic mechanisms has an important role in tumor progression (Ahuja et al., 1997; Dong et al., 2001; Fujii et al., 1998; Kanai et al., Melki et al., 1999; Rood et al., 2002; Yamanaka et al., 2003) . However, little is known about the role of HIC1 in the pathogenesis of GC.
Molecules and Cells
Another notable candidate gene in the overlapping LOH subregion in chromosome 17q21.33 (SR 3 ) is TOB1 (transducer of ERBB-2, 1). TOB1 is a member of the TOB/BTG antiproliferation protein family. Overexpression of the TOB family proteins results in cell growth retardation (Suzuki et al., 2001) , while TOB LOH (Fong et al., 1995) and decreased TOB expression (Iwanaga et al., 2003) were observed in lung cancer tissues. Moreover, mice lacking the TOB gene developed tumors in the lung, liver, and lymph nodes (Yoshida et al., 2003) , suggesting the importance of the TOB gene in these tumors. However, the role of this gene has not been determined in GC.
To determine the biological significance of HIC1 and TOB1 in gastric tumorigenesis, we investigated their expression patterns and/or promoter methylation status by immunohistochemistry (IHC) analysis, methylation-specific polymerase chain reaction (MSP)/RT-PCR, and/or Western blotting of a series of primary GCs, GC tissue microarrays and GC cell lines. We showed that aberrant methylation and reduced expression of HIC1, as well as downregulated TOB1 expression and the ratio of unphosphorylated to phosphorylated TOB1 protein are common in GC and could serve as potential markers for GC development.
MATERIALS AND METHODS

Cell lines
Four GC cell lines (moderately differentiated SGC-7901; poorly differentiated BGC-823; MGC-803; and undifferentiated HGC-27) and human embryonic kidney 293 cells (HEK 293) were obtained from the Cell Resources Center of Shanghai Life Sciences, Chinese Academy of Sciences (China). Cells were cultured according to the supplier's recommendations.
Tissue specimens
Forty-five paired specimens of GCs and corresponding noncancerous gastric tissues for LOH analysis and thirty pairs of cancerous and adjacent non-cancerous tissues of fresh gastric adenocarcinomas, for both expression and methylation analysis, and Twenty-six pairs of formalin-fixed and paraffin-embedded specimens for immunohistochemistry analysis, were obtained at the First, Second and Third Affiliated Hospitals, Harbin Medical University in Harbin, Heilongjiang Province, People's Republic of China. All diagnoses were confirmed by routine histologic examination and patients had received no treatment before surgery.
Tissue microarrays
A set of GC tissue microarrays, purchased from Beijing Friendship Hospital (China), were used in the immunohistochemistry analysis，which contained 80 cancerous and non-cancerous tissue pairs, respectively. Each GC tissue sample came with detailed information regarding the patient, including gender, age and tumor histotype.
All the work involving human samples was carried out in accordance with The Code of the World Medical Association (Declaration of Helsinki). This project was approved by the Ethics Committee of Harbin Medical University and appropriate informed consent was obtained from all participating patients.
Microsatellite analysis for LOH
Thirty-six microsatellite markers, distributed over three overlapping deleted regions (18 in R 1 , 9 in R 2 and 9 in R 3 ) on chromosome 17, were used for this study. Nine markers (D17S1852, D17S938, D17S831, D17S784, D17S928, D17S787, D17S785, D17S921, and D17S1868), which were used in our previous work (Yu et al., 2008) , are listed in Fig. 2 and Table 1 . PCR primers were synthesized according to the primer sequences obtained from the Genome Database (http://www.gdb.org; Table 1 ). One primer of each pair was labeled with either one of two fluorescent dyes (FAM, HEX) at the 5′-end. Multiplex PCR analysis was performed and LOH was scored as previously described (Yu et al., 2008) . The LOH frequency of one site was indicated by the percentage of the allelic losses and all informative cases.
Immunohistochemistry
Immunohistochemical staining using antibodies against HIC1 (rabbit polyclonal, 1:200 dilution, Abcam, USA) and TOB1 (mouse monoclonal, 1:1200 dilution; Sigma, USA) was performed as previously described (Park et al., 2006) . Global staining of HIC1 and TOB1 was scored as 0 (no staining), 1+ (focus or weak), 2+ (moderate 25%-50%), 3+ (strong 25%-50%) and 4+ (strong > 50%).
Methylation-specific PCR
Methylation-specific PCR was conducted as described previously (Herman et al., 1996) . The primers for the methylated sequence of the HIC1 promoter region were 5′-TCGGTTTT CGCGTTTTGTTCGT-3′ (sense), 5′-AACCGAAAACTATCAAC CCTCG-3' (antisense), and those for the unmethylated sequences of the promoter region for HIC1 were 5′-TTGGGTT TGGTTTTTGTGTTTTG-3′ (sense), 5′-CACCCTAACACCACC CTAAC-3′ (antisense). The 5′ ends of the unmethylated and methylated sense primers are locate in the bp 20 and 26 position of the genome sequence (GenBank accession number L41919), and -617 and -611 relative to the HIC1 transcription start site, respectively (Dong et al., 2001) . The MSP products were then separated in 2% agarose gels stained with ethidium bromide and visualized under UV light. Normal lymphocyte DNA treated with Sss1 methyltransferase (New England Biolabs, USA) was used as a positive control for methylated alleles, and DNA from normal lymphocytes was used as a negative control for methylated alleles.
Reverse transcriptase-polymerase chain reaction RT-PCR was performed according to the standard method. The primers used to amplify TOB1 (GenBank accession No.: NM_005749) mRNA were 5′-ATCAGTGTCCAGCTCTCCATC-3′ (sense) and 5′-CCATAGGCTGCAAACACATC-3′ (antisense). ACTB was used as the internal control, primer sequences were 5′-ACTCTTCCAGCCTTCCTTCC-3′ (sense) and 5′-CAT ACTCCTGCTTGCTGATCC-3′ (antisense). The PCR products were separated electrophoretically in a 1.5% agarose gel and visualized by ethidium bromide staining.
Western-blot analysis
Whole cell lysates were prepared using RIPA buffer containing 150 mM NaCl, 1% TritonX-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mmol/L Tris base, 10% protease inhibitor (Sigma, USA). Protein (100 μg) was separated by SDS-PAGE (12%), transferred to PVDF membranes (Millipore, USA), blocked with 5% defatted milk at 4°C overnight, and incubated at room temperature with the primary antibodies at a dilution of 1:250 and the corresponding secondary antibodies (Sigma, USA), for 1 h for each incubation, and finally visualized using an enhanced chemiluminescence detection system (Amersham, USA). Scion Image tool software (info@scioncorp.com) was used to analyze and quantify the scanned protein bands.
